Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease

Details for Australian Patent Application No. 2007213194 (hide)

Owner Kyorin Pharmaceutical Co., Ltd.

Inventors Nakamaru, Koichi; Kojima, Ryotaro; Yasue, Tokutarou

Agent Griffith Hack

Pub. Number AU-A-2007213194

PCT Pub. Number WO2007/091501

Priority 2006-027883 06.02.06 JP

Filing date 5 February 2007

Wipo publication date 16 August 2007

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/091501 Priority application(s): WO2007/091501

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007213211-Process for hydrogenation of wax and process for production of fuel base

2007213183-Water-in-oil emulsion type sunscreen preparation